COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 458.7 | 5 | 0120-0440 | 203.93 | 440.29 | 462 | 83.84 | 0.826 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 294.4 | 5 | 0121-0442 | 226.39 | 442.23 | 462 | 81.60 | 0.872 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 361.7 | 5 | 0122-0442 | 259.99 | 441.96 | 399 | 75.50 | 0.880 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 226.0 | 5 | 0123-0442 | 396.28 | 441.63 | 404 | 77.26 | 0.851 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1755.0 | 5 | 0124-0452 | 828.09 | 451.93 | 481 | 81.01 | 0.921 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 666.7 | 5 | 0125-0454 | 567.20 | 454.24 | 407 | 76.08 | 0.884 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 280.7 | 5 | 0126-0458 | 60.38 | 458.16 | 396 | 77.26 | 0.834 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 368.7 | 5 | 0127-0464 | 462.94 | 463.98 | 444 | 82.91 | 0.812 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 223.3 | 5 | 0128-0462 | 682.87 | 461.98 | 412 | 76.91 | 0.875 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1549.1 | 5 | 0129-0466 | 727.81 | 466.33 | 689 | 100.47 | 0.858 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 273.4 | 5 | 0130-0462 | 939.93 | 462.33 | 386 | 73.01 | 0.910 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 257.4 | 5 | 0131-0480 | 545.63 | 480.82 | 800 | 118.71 | 0.713 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 410.8 | 5 | 0132-0475 | 595.64 | 476.17 | 420 | 82.33 | 0.779 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 278.6 | 5 | 0133-0486 | 337.27 | 486.65 | 436 | 83.40 | 0.788 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 215.5 | 5 | 0134-0487 | 654.85 | 487.16 | 421 | 78.91 | 0.850 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 328.5 | 5 | 0135-0498 | 312.01 | 498.08 | 791 | 114.95 | 0.752 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 203.9 | 5 | 0136-0500 | 732.05 | 500.30 | 421 | 78.91 | 0.850 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 290.5 | 5 | 0137-0510 | 41.05 | 510.31 | 392 | 74.67 | 0.884 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 312.6 | 5 | 0138-0511 | 901.81 | 511.56 | 447 | 79.50 | 0.889 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 291.3 | 5 | 0139-0514 | 171.32 | 513.56 | 408 | 78.57 | 0.831 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 445.0 | 5 | 0140-0515 | 814.29 | 515.03 | 404 | 77.26 | 0.851 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 278.8 | 5 | 0141-0517 | 762.03 | 517.57 | 409 | 75.84 | 0.894 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 287.9 | 5 | 0142-0518 | 524.67 | 518.08 | 411 | 77.26 | 0.865 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 255.0 | 5 | 0143-0530 | 669.23 | 530.32 | 405 | 76.67 | 0.866 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 625.9 | 5 | 0144-0535 | 381.83 | 535.94 | 398 | 75.01 | 0.889 |